New drug cocktail tested for Tough-to-Treat leukemia in frail patients
Disease control
Terminated
This early-stage study tested the safety of combining three drugs—uproleselan, azacitidine, and venetoclax—for older adults or those too frail for standard intensive chemotherapy who have newly diagnosed acute myeloid leukemia (AML). The goal was to find a safe dose and see if th…
Phase: PHASE1 • Sponsor: Brian Jonas • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC